1
|
Dündar Yenilmez E, Tuli A. Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy. Balkan Med J 2023; 40:279-286. [PMID: 37154826 PMCID: PMC10339851 DOI: 10.4274/balkanmedj.galenos.2023.2023-1-86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2023] [Accepted: 04/13/2023] [Indexed: 05/10/2023] Open
Abstract
Background Hemoglobinopathies are the most common inherited diseases in humans resulting from impaired globin chain synthesis of hemoglobin. The progression of thalassemia rates is prevented with prenatal screening methods. Aims To evaluate the hematological parameters of α- and β-thalassemia and normal fetuses aged 17-25 weeks of gestation. Study Design A cross-sectional study. Methods Pregnant women who underwent cordocentesis in the second trimester because of the risk of having a baby with thalassemia were included in the study. Hematological indices and molecular DNA methods were analyzed from the cord blood samples of 129 women who were 17-25 weeks into pregnancy. The HPLC method was used for Hb fraction analysis. Amplification refractory mutation system, restriction enzyme analysis, multiplex polymerase chain reaction, and sequencing methods were used for the molecular analysis. Maternal contamination was eliminated by the short tandem repeat method. Results In total, 112 of the fetuses carry α- and β-thalassemia heterozygous or homozygous (α: 37, β: 58, mixed: 17) and 17 fetuses had a normal genotype for thalassemia. Significant differences in adult hemoglobin (HbA), fetal hemoglobin (HbF), Hb Barts, MCV, MCH, and RDW were detected in three groups compared with the normal group (p < 0.001, except for RBC, Hb, HCT, and MCHC). Differences in HbF, Hb Barts, MCV, MCH, and RDW were observed in the α-thalassemia groups compared with the normal group (p < 0.001). Among the five β-thalassemia subgroups, only HbA and RDW were different from the normal group (p < 0.001). Conclusion This study could be a good reference for future studies and prenatal diagnostic applications in emphasizing the importance of changes in the blood parameters of fetuses before molecular genotyping. These hematological data give valuable information to clinicians about the fetus to enlighten families in making appropriate decisions during prenatal diagnosis.
Collapse
Affiliation(s)
- Ebru Dündar Yenilmez
- Department of Medical Biochemistry, Faculty of Medicine, Çukurova University, Adana, Turkey
| | - Abdullah Tuli
- Department of Medical Biochemistry, Faculty of Medicine, Çukurova University, Adana, Turkey
| |
Collapse
|
2
|
Colah RB, Nadkarni AH, Gorakshakar AC, Sawant PM, Mehta PR, Gorivale MS, Hariharan P, Mohanty D, Ghosh K. The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades. Hemoglobin 2021; 45:112-118. [PMID: 33829933 DOI: 10.1080/03630269.2021.1908346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The β-thalassemias and sickle cell disorders pose a considerable health burden in India. Of the more than 10,000 annual births of children with a severe hemoglobinopathy, only around 10.0% are managed optimally. Thus, genetic counseling and prenatal diagnosis (PND) is a valid option for a large and diverse country. Our center was one of the first to initiate PND and we present our experience over 30 years to evaluate the impact of awareness in changing the trends of PND of hemoglobinopathies. Both second and first-trimester diagnoses were undertaken by fetoscopy/cordocentesis and globin biosynthesis/high-performance liquid chromatography (HPLC) analysis of fetal blood and chorionic villus sampling (CVS) and DNA analysis. Over 30 years, 3478 couples (first trimester: 2475; second trimester: 1003) from all over India were offered PND. The number of couples coming in the first trimester increased significantly over each decade and couples coming prospectively increased from 2.5 to 18.4%. A cost-effective stepwise approach was used for molecular analysis. Eight hundred and one fetuses (23.0%) were affected and all except three couples opted for termination of these pregnancies. Genetic counseling and PND is the only way to reduce the burden of disease. With awareness, there was a shift from second trimester to first trimester PND over each decade, with an increasing number of couples coming during the first pregnancy. There are only 15 to 20 centers in India offering PND. We have compared our study with other reports on PND from different regions in India.
Collapse
Affiliation(s)
- Roshan B Colah
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Anita H Nadkarni
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Ajit C Gorakshakar
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Pratibha M Sawant
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Pallavi R Mehta
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Manju S Gorivale
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Priya Hariharan
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Dipika Mohanty
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| | - Kanjaksha Ghosh
- Department of Haematogenetics, Indian Council of Medical Research, National Institute of Immunohaematology, Mumbai, India
| |
Collapse
|
3
|
Huang LY, Li J, Zhang Y, Li DZ. A KLF1
gene mutation causes β-thalassemia minor in a Chinese family. Int J Lab Hematol 2018; 40:e35-e37. [DOI: 10.1111/ijlh.12788] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2017] [Accepted: 01/16/2018] [Indexed: 11/29/2022]
Affiliation(s)
- L.-Y. Huang
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| | - J. Li
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| | | | - D.-Z. Li
- Guangzhou Women and Children Medical Center affiliated to Guangzhou Medical University; Guangzhou Guangdong China
| |
Collapse
|
4
|
Rao S, Saxena R, Deka D, Kabra M. Use of HbA estimation by CE-HPLC for prenatal diagnosis ofβ-thalassemia; experience from a tertiary care centre in north India: a brief report. Hematology 2013; 14:122-4. [DOI: 10.1179/102453309x385269] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Affiliation(s)
- Seema Rao
- Department of HematologyAll India Institute of Medical Sciences, New Delhi 110029, India
| | - Renu Saxena
- Department of HematologyAll India Institute of Medical Sciences, New Delhi 110029, India
| | - Deepika Deka
- Department of Obstetrics and GynaecologyAll India Institute of Medical Sciences, New Delhi 110029, India
| | - Madhulika Kabra
- Department of PediatricsAll India Institute of Medical Sciences, New Delhi 110029, India
| |
Collapse
|
5
|
Italia K, Sawant P, Surve R, Wadia M, Nadkarni A, Ghosh K, Colah R. Variable haematological and clinical presentation of β-thalassaemia carriers and homozygotes with the Poly A (T→C) mutation in the Indian population. Eur J Haematol 2012; 89:160-4. [PMID: 22690826 DOI: 10.1111/j.1600-0609.2012.01810.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/22/2012] [Indexed: 11/29/2022]
Abstract
OBJECTIVES To study the varied clinical and haematological profile of β-thalassaemia homozygotes, compound heterozygotes and heterozygotes with the Poly A (T→C) mutation and its implication in prenatal diagnosis. MATERIALS AND METHODS Forty individuals were included in the study. Peripheral smear examination, complete blood count and haemoglobin analysis were carried out. β-thalassaemia mutation analysis was carried out by reverse-dot-blot hybridization, amplification refractory mutation system and DNA sequencing of the β-globin gene. RESULTS Five of the six β-thalassaemia homozygotes with the Poly A (T→C) mutation and five individuals who were compound heterozygous for the Poly A (T→C) mutation along with another common Indian β-thalassaemia mutation showed a severe β-thalassaemia major phenotype, while one individual presented as a thalassaemia intermedia. Majority of the 28 heterozygous individuals with this mutation showed borderline HbA₂ (mean HbA₂ = 3.7 ± 0.4%) levels as compared to individuals with common β-thalassaemia mutations (mean HbA₂ = 5.2 ± 1.4%). The Mean Corpuscular Volume (MCV) levels in individuals heterozygous for the Poly A (T→C) mutation (mean MCV 70.0 ± 5.2 fl) were significantly higher than in individuals with other common β-thalassaemia mutations (mean MCV 60.7 ± 7.7 fl) (P < 0.001). CONCLUSION It is important to identify these often silent carriers of β-thalassaemia for prenatal diagnosis as homozygotes have a severe disease.
Collapse
Affiliation(s)
- Khushnooma Italia
- National Institute of Immunohaematology, Indian Council of Medical Research, Parel, Mumbai, India
| | | | | | | | | | | | | |
Collapse
|
6
|
Verma IC, Saxena R, Kohli S. Hemoglobinopathies in India—Clinical and Laboratory Aspects. Clin Lab Med 2012; 32:249-62. [DOI: 10.1016/j.cll.2012.04.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Italia KY, Sawant PM, Nadkarni AH, Ghosh K, Colah RB. Is the poly A (T>C) mutation a causative factor for misdiagnosis in second trimester prenatal diagnosis of β-thalassemia by fetal blood analysis on high performance liquid chromatography? Hemoglobin 2012; 36:114-23. [PMID: 22296681 DOI: 10.3109/03630269.2011.654144] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
We report the problems in diagnosis faced by two families referred for prenatal diagnosis of thalassemia where cordocentesis and fetal blood analysis by high performance liquid chromatography (HPLC) had to be done. The Hb A levels of the fetal blood measured by HPLC on the VARIANT™ Hemoglobin Testing System were 1.2 and 6.7%, respectively, suggestive of a heterozygous β-thalassemia (β-thal) fetus in the first case and a normal fetus in the second case. In one family, one of the parents had a borderline Hb A(2) level and in the other, one parent had normal RBC indices. However, DNA sequencing, done later, showed that in the first case the fetus was a compound heterozygote for the IVS-I-5 (G>C) and the polyadenylation signal site [poly A (T>C)] mutation, while in the second case, the fetus was homozygous for the poly A mutation. This emphasizes that characterization of β-thal mutations must be done whenever one of the parents has a borderline Hb A(2) level or normal RBC indices, and one should not rely on fetal blood analysis by HPLC for prenatal diagnosis of β-thal so as to avoid misdiagnosis.
Collapse
Affiliation(s)
- Khushnooma Y Italia
- National Institute of Immunohematology, King Edward Memorial Hospital Campus, Parel, Mumbai, India
| | | | | | | | | |
Collapse
|
8
|
Ghosh K. Haematology research in India: past, present and future. Indian J Hematol Blood Transfus 2011; 27:55-64. [PMID: 22654293 PMCID: PMC3136671 DOI: 10.1007/s12288-011-0062-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2008] [Accepted: 03/21/2011] [Indexed: 10/18/2022] Open
Abstract
Haematology research in India is relatively recent in origin. However the pioneers in the field not only did exemplary work when compared to advanced western countries, they also made it a point to develop centres of excellence and human resources for future of haematology work in this country. In this brief overview an effort has been made to give a taste of quality and expanse of haematology research in this country. This review does not claim to have described every bit of haematology research in this country. Our pioneers worked under extremely difficult and trying circumstances on a subject which was limited to funding available from Indian Council of Medical Research. Now the times have changed, several funding agencies in the country are able to provide substantial fund for research. Modern state of the art basic research institutions are tying up with medical colleges for good quality research and the seeds which our pioneers had planted have grown into a mighty tree. It would not be an exaggeration to say we are on the threshold of the golden era of haematology research in this country.
Collapse
Affiliation(s)
- Kanjaksha Ghosh
- National Institute of Immunohaematology, 13th Fl KEM Hospital, Parel, Mumbai, 400012 India
| |
Collapse
|
9
|
GOSSELIN RC, CARLIN AC, DWYRE DM. Comparison of the BioRad Variant and Primus Ultra2 high-pressure liquid chromatography (HPLC) instruments for the detection of variant hemoglobins. Int J Lab Hematol 2010; 33:159-67. [DOI: 10.1111/j.1751-553x.2010.01260.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Madan N, Sharma S, Sood SK, Colah R, Bhatia LHM. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. INDIAN JOURNAL OF HUMAN GENETICS 2010; 16:16-25. [PMID: 20838487 PMCID: PMC2927789 DOI: 10.4103/0971-6866.64941] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
INTRODUCTION India is an ethnically diverse country with an approximate population of 1.2 billion. The frequency of beta-thalassemia trait (βTT) has variously been reported from <1% to 17% and an average of 3.3%. Most of these studies have been carried out on small population groups and some have been based on hospital-based patients. There is also a variation in the prevalence of hemoglobinopathies in different regions and population groups in the country. A high frequency of Hb D has been reported from the North in the Punjabi population, Hb E in the eastern region of India and Hb S is mainly reported from populations of tribal origin from different parts of the country. OBJECTIVES To study the gene frequency of βTT and other hemoglobinopathies in three regions East (Kolkata), West (Mumbai) and North (Delhi) in larghe population group (schoolchildren) for a more accurate assessment of gene frequency for planning of control programmes for haemoglobinopathies. MATERIALS AND METHODS This study included 5408 children from 11 schools in Delhi, 5682 from 75 schools in Mumbai and 957 schoolchildren from Kolkata who were screened for βTT and haemoglobinopathies. These included 5684 children from 75 schools in Mumbai and 5408 children from 11 schools in Delhi. Children were 11-18 years of age of both sexes. The final report is, however, only on 11090 schoolchildren from Mumbai and Delhi as data from Kolkata was restricted both in numbers and objectives and could not be included for comparison. RESULTS The overall gene frequency of βTT in Mumbai and Delhi was 4.05% being 2.68% and 5.47% in children of the two cities respectively. In Mumbai, the gene frequency was evenly distributed. Majority of the children with βTT from Mumbai were from Marathi (38.9%) and Gujarati (25%) speaking groups. Gene frequency was >5% in Bhatias, Khatris, Lohanas and Schedule Castes. In Delhi, a higher incidence was observed in schoolchildren of North and West Delhi (5.8-9.2%). The schoolchildren of North and West Delhi comprised predominantly of Punjabi origin compared to children in the South of the city (2.2%, 2.3%). When analyzed state-wise, the highest incidence was observed in children of Punjabi origin (7.6%) and was >4% from several other states. Majority of the traits from Mumbai were anemic (95.1% male and 85.6% in female). The prevalence of anemia was lower (62.7% male and 58.4% female) children with βTT from Delhi. This was a reflection of the higher prevalence of anemia in children without hemoglobinopathy in Mumbai than in Delhi. Nutritional deficiency was probably more severe and rampant in children Mumbai. Gene frequency of Hb D was greater in schoolchildren from Delhi (1.1%) than in Mumbai (0.7%). Hb S trait (0.2%) was observed exclusively in children from Mumbai. A low incidence of Hb E trait (0.04%) was seen in children in Mumbai. A higher incidence is reported from the East. The number of cases studied from the eastern region was small as the data from the East (Kolkata) could not be included in the analysis. CONCLUSION This study comprises a larger number of children studied for the gene frequency of βTT and other hemoglobinopathies from India. Population groups with higher gene frequencies require screening programmes and facilities for antenatal diagnosis as well as increased awareness and educational programmes to control the birth of thalassemic homozygotes. The overall carrier frequency of βTT was 4.05% and reinforces the differential frequency of β-thalassemia trait in schoolchildren from Delhi and Mumbai and the higher incidence of hemoglobin D in Punjabis as reported previously. The birth incidence calculated thereof for homozygous thalassemics would be 11,316 per year which are added each year to the existing load of homozygous thalassemics. This is much higher than the previously reported number of births annually. Hence suitable control measures need to be undertaken urgently in India.
Collapse
Affiliation(s)
- Nishi Madan
- Department of Pathology, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi 110 095, India
| | | | | | | | | |
Collapse
|
11
|
Sirichotiyakul S, Saetung R, Sanguansermsri T. Prenatal Diagnosis of β-Thalassemia/Hb E by Hemoglobin Typing Compared to DNA Analysis. Hemoglobin 2009; 33:17-23. [DOI: 10.1080/03630260802626046] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Colah R, Surve R, Wadia M, Solanki P, Mayekar P, Thomas M, Gorakshakar A, Dastur A, Mohanty D. Carrier Screening for β-Thalassemia during Pregnancy in India: A 7-Year Evaluation. ACTA ACUST UNITED AC 2008; 12:181-5. [DOI: 10.1089/gte.2007.0066] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Roshan Colah
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Reema Surve
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Marukh Wadia
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Prakash Solanki
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Pramod Mayekar
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Mariamma Thomas
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Ajit Gorakshakar
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| | - Adi Dastur
- N. Wadia Maternity Hospital, Parel, Mumbai, India
| | - Dipika Mohanty
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India
| |
Collapse
|
13
|
Colah RB, Surve R, Sawant P, D'Souza E, Italia K, Phanasgaonkar S, Nadkarni AH, Gorakshakar AC. HPLC studies in hemoglobinopathies. Indian J Pediatr 2007; 74:657-62. [PMID: 17699975 DOI: 10.1007/s12098-007-0117-8] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
An accurate diagnosis of beta -thalassemia carriers, homozygous patients and identification of different structural hemoglobin variants is important for epidemiological studies as well as for management and prevention of the major hemoglobin disorders. There are many electrophoretic and chromatographic approaches for estimation of HbA2 and Hb F but cation exchange HPLC (CE-HPLC)using automated dedicated machines like the Variant Hb testing system have become the method of choice for these investigations. CE-HPLC also helps in the presumptive identification of many abnormal hemoglobin variants and has been useful for both neonatal screening of sickle cell disease as well as second trimester prenatal diagnosis of thalassemia by fetal blood analysis. Other applications of HPLC in hemoglobinopathies include separation of globin chains, measuring the ratio of gamma globin chains (Ggamma/Agamma) and the recently described denaturing HPLC for detecting mutations in both alpha and beta globin genes.
Collapse
Affiliation(s)
- R B Colah
- Institute of Immunohaematology (ICMR), 13th Floor, New Multistoreyed Building, KEM Hospital Campus, Parel, Mumbai, India.
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Colah R, Surve R, Nadkarni A, Gorakshakar A, Phanasgaonkar S, Satoskar P, Mohanty D. Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling. Prenat Diagn 2005; 25:345-9. [PMID: 15906420 DOI: 10.1002/pd.1131] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
OBJECTIVES The sickle gene is prevalent in the scheduled caste and tribal populations in India. The clinical presentation of sickle cell disease is extremely variable, and there are no neonatal screening programmes. This is the first report on prenatal diagnosis of sickle syndromes in 85 couples at risk (sickle cell anemia-69; sickle thalassemia-16) from different regions in India. Most of the couples were from a low socioeconomic group and their decisions were entirely dependent on the local counselling given. We have evaluated the acceptability of prenatal diagnosis and the dilemmas faced in counselling these families. METHODS Chorion villus sampling was done in the first trimester and DNA analysis using reverse dot blot hybridization or restriction enzyme digestion with Dde1 in 65 cases. Cordocentesis was done in the second trimester and fetal blood analyses by automated HPLC in 20 cases who came late. RESULTS 32.9% of couples came prospectively for diagnosis. 23.5% of fetuses were affected (sickle cell anemia-18, sickle thalassemia-2). The beta-thalassemia mutation in both cases was IVS 1-5(G->C). All the couples with an unfavourable diagnosis opted for termination of pregnancy. CONCLUSION Sickle cell anemia has a relatively benign clinical course in some tribal groups in India. This raises a dilemma whether we are justified in advising prenatal diagnosis in all such cases.
Collapse
Affiliation(s)
- Roshan Colah
- Institute of Immunohaematology (ICMR), KEM Hospital Campus, Parel, Mumbai, India.
| | | | | | | | | | | | | |
Collapse
|
15
|
Mohanty D, Colah RB, Gorakshakar AC, Nadkarni AH, Phanasgaonkar SP, Shetty S, Ghosh K, Mukherjee MB. Genetic Disorders in Haematological Practice in India. ACTA ACUST UNITED AC 2002; 5:197-200. [PMID: 14960892 DOI: 10.1159/000066336] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Haemoglobinopathies represent a significant national health burden in India. The distribution of specific disorders varies geographically and by community. Heterozygote frequencies of beta-thalassaemia range from 1 to 15%, resulting in an estimated 20 million carriers. HbS is mainly present in tribal and non-caste communities, with carrier prevalences of up to 40%. By comparison, alpha-thalassaemia carriers are found in both the caste and tribal communities, and can reach a frequency of >90% in the latter case. Community control of haemoglobinopathies relies mainly on out-reach education programmes and genetic counselling, with antenatal diagnosis offered in specific major centres. Only partial data are available on the prevalence of haemophilia, but it has been estimated that there are some 50,000 affected individuals nationwide, with an additional 1,500 new cases born each year. RFLP-based techniques have been established to detect mutations in the factor VIII and IX genes, enabling the limited introduction of carrier detection and antenatal diagnosis.
Collapse
Affiliation(s)
- D Mohanty
- Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India.
| | | | | | | | | | | | | | | |
Collapse
|